| Symbol |
Name |
|
ACVR1
|
activin A receptor, type I
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAP2
|
ArfGAP with dual PH domains 2
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
ALPK2
|
alpha-kinase 2
|
|
ALPK3
|
alpha-kinase 3
|
|
APELA
|
apelin receptor early endogenous ligand
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
BCOR
|
BCL6 corepressor
|
|
BMP10
|
bone morphogenetic protein 10
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BORCS8
|
BLOC-1 related complex subunit 8
|
|
BVES
|
blood vessel epicardial substance
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACYBP
|
calcyclin binding protein
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCM2L
|
cerebral cavernous malformation 2-like
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CER1
|
cerberus 1, DAN family BMP antagonist
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
CRELD1
|
cysteine-rich with EGF-like domains 1
|
|
CRIP1
|
cysteine-rich protein 1 (intestinal)
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
DAND5
|
DAN domain family member 5, BMP antagonist
|
|
DNAAF4
|
dynein axonemal assembly factor 4
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
DZIP1
|
DAZ interacting zinc finger protein 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EEF1AKMT4-ECE2
|
EEF1AKMT4-ECE2 readthrough
|
|
EPHB4
|
EPH receptor B4
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
FBN1
|
fibrillin 1
|
|
FGF12
|
fibroblast growth factor 12
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2
|
|
FLRT3
|
fibronectin leucine rich transmembrane protein 3
|
|
FN1
|
fibronectin 1
|
|
FOXC1
|
forkhead box C1
|
|
FOXC2
|
forkhead box C2
|
|
FOXF1
|
forkhead box F1
|
|
FOXL1
|
forkhead box L1
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GLI2
|
GLI family zinc finger 2
|
|
GPC3
|
glypican 3
|
|
HAND1
|
heart and neural crest derivatives expressed 1
|
|
HAND2
|
heart and neural crest derivatives expressed 2
|
|
HDAC9
|
histone deacetylase 9
|
|
HEG1
|
heart development protein with EGF-like domains 1
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IFT122
|
intraflagellar transport 122
|
|
INSR
|
insulin receptor
|
|
ISL1
|
ISL LIM homeobox 1
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
LDB3
|
LIM domain binding 3
|
|
LEFTY1
|
left-right determination factor 1
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2BNB-MEF2B
|
MEF2BNB-MEF2B readthrough
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MEGF8
|
multiple EGF-like-domains 8
|
|
MESP1
|
mesoderm posterior basic helix-loop-helix transcription factor 1
|
|
MESP2
|
mesoderm posterior basic helix-loop-helix transcription factor 2
|
|
MICAL2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2
|
|
MIXL1
|
Mix paired-like homeobox
|
|
MKKS
|
McKusick-Kaufman syndrome
|
|
MMP23A
|
matrix metallopeptidase 23A (pseudogene)
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYL7
|
myosin, light chain 7, regulatory
|
|
MYOCD
|
myocardin
|
|
NCOA6
|
nuclear receptor coactivator 6
|
|
NDRG4
|
NDRG family member 4
|
|
NDUFV2
|
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa
|
|
NF1
|
neurofibromin 1
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX2-6
|
NK2 homeobox 6
|
|
NOTCH1
|
notch 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
OXSR1
|
oxidative stress responsive 1
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDLIM1
|
PDZ and LIM domain 1
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDLIM3
|
PDZ and LIM domain 3
|
|
PDLIM4
|
PDZ and LIM domain 4
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
|
PHIP
|
pleckstrin homology domain interacting protein
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP2
|
plakophilin 2
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
POLR2D
|
polymerase (RNA) II (DNA directed) polypeptide D
|
|
POPDC2
|
popeye domain containing 2
|
|
POPDC3
|
popeye domain containing 3
|
|
POU4F1
|
POU class 4 homeobox 1
|
|
POU4F2
|
POU class 4 homeobox 2
|
|
POU6F1
|
POU class 6 homeobox 1
|
|
PRICKLE4
|
prickle homolog 4 (Drosophila)
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SCUBE1
|
signal peptide, CUB domain, EGF-like 1
|
|
SGCD
|
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
|
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
|
|
SGCZ
|
sarcoglycan, zeta
|
|
SH3PXD2B
|
SH3 and PX domains 2B
|
|
SHH
|
sonic hedgehog
|
|
SMG9
|
SMG9 nonsense mediated mRNA decay factor
|
|
SMYD4
|
SET and MYND domain containing 4
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRI
|
sorcin
|
|
STRA6
|
stimulated by retinoic acid 6
|
|
SYNPO2L
|
synaptopodin 2-like
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAZ
|
tafazzin
|
|
TBX1
|
T-box 1
|
|
TBX19
|
T-box 19
|
|
TBX2
|
T-box 2
|
|
TBX3
|
T-box 3
|
|
TBX5
|
T-box 5
|
|
TCAP
|
titin-cap
|
|
TCF25
|
transcription factor 25 (basic helix-loop-helix)
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TH
|
tyrosine hydroxylase
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TSC2
|
tuberous sclerosis 2
|
|
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WT1
|
Wilms tumor 1
|
|
ZDHHC16
|
zinc finger, DHHC-type containing 16
|
|
ZFPM1
|
zinc finger protein, FOG family member 1
|
|
ZFPM2
|
zinc finger protein, FOG family member 2
|
